Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
Sage Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 29, 2021
Sage Therapeutics reported fiscal year 2018 executive compensation information on April 29, 2021.
In 2018, six executives at Sage Therapeutics received on average a compensation package of $4.7M, a 6% increase compared to previous year.
Average pay of disclosed executives at Sage Therapeutics
Jeffrey M. Jonas, Chief Executive Officer, received $9.8M in total, which increased by 71% compared to 2017. 89% of Jonas' compensation, or $8.7M, was in option awards. Jonas also received $424K in non-equity incentive plan, $642K in salary, as well as $17K in other compensation.
For fiscal year 2018, the median employee pay was $589,166 at Sage Therapeutics. Therefore, the ratio of Jeffrey M. Jonas' pay to the median employee pay was 17 to one.
Michael Cloonan, Chief Business Officer, received a compensation package of $4.2M, which decreased by 59% compared to previous year. 84% of the compensation package, or $3.5M, was in option awards.
Anne Marie Cook, General Counsel, earned $3.7M in 2018, a 50% increase compared to previous year.
Albert J. Robichaud, Chief Scientific Officer, received $3.7M in 2018.
Kimi Iguchi, Chief Financial Officer, earned $3.7M in 2018, a 78% increase compared to previous year.
Stephen J. Kanes, Chief Medical Officer, received $3.3M in 2018, which increases by 65% compared to 2017.
Related executives
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Kimi Iguchi
Sage Therapeutics
Chief Financial Officer
Michael Cloonan
Sage Therapeutics
Chief Operating Officer
Anne Cook
Sage Therapeutics
General Counsel
Stephen Kanes
Sage Therapeutics
Chief Medical Officer
You may also like
Source: SEC filing on April 29, 2021.